Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7855)
All Articles published online
|
Jun 14, 2005 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, Sripa C, Miwa M. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 2005; 11(22): 3392-3397 [PMID: 15948244 DOI: 10.3748/wjg.v11.i22.3392] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i22/3392.htm |
| Number | Citing Articles |
| 1 |
Ponlapat Yonglitthipagon, Chawalit Pairojkul, Yaovalux Chamgramol, Alex Loukas, Jason Mulvenna, Jeffrey Bethony, Vajarabhongsa Bhudhisawasdi, Banchob Sripa. Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin–binding phosphoprotein 50 in cholangiocarcinoma. Human Pathology 2012; 43(10): 1719 doi: 10.1016/j.humpath.2011.11.021
|
| 2 |
Supharada Tessiri, Anchalee Techasen, Sarinya Kongpetch, Achira Namjan, Watcharin Loilome, Waraporn Chan-on, Raynoo Thanan, Apinya Jusakul. Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. PeerJ 2022; 10: e12750 doi: 10.7717/peerj.12750
|
| 3 |
Somsiri Indramanee, Kanlayanee Sawanyawisuth, Atit Silsirivanit, Paweena Dana, Chatchai Phoomak, Ryusho Kariya, Nathakan Klinhom-on, Supannika Sorin, Chaisiri Wongkham, Seiji Okada, Sopit Wongkham. Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53601-8
|
| 4 |
Kornkamon Lertsuwan, Supathra Phoaubon, Nathapol Tasnawijitwong, Jomnarong Lertsuwan. Adenosine Suppresses Cholangiocarcinoma Cell Growth and Invasion in Equilibrative Nucleoside Transporters-Dependent Pathway. International Journal of Molecular Sciences 2020; 21(3): 814 doi: 10.3390/ijms21030814
|
| 5 |
UMAWADEE LAOTHONG, YUSUKE HIRAKU, SHINJI OIKAWA, KITTI INTUYOD, MARIKO MURATA, SOMCHAI PINLAOR. Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen species-mediated mitochondrial pathway. Oncology Reports 2015; 33(3): 1443 doi: 10.3892/or.2015.3738
|
| 6 |
Kawin Leelawat, Wandee Udomchaiprasertkul, Siriluck Narong, Surang Leelawat. Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells. Journal of Cancer Research and Clinical Oncology 2010; 136(10): 1537 doi: 10.1007/s00432-010-0811-1
|
| 7 |
Suman Dutta, Onrapak Reamtong, Wittaya Panvongsa, Sarunya Kitdumrongthum, Keatdamrong Janpipatkul, Polkit Sangvanich, Pawinee Piyachaturawat, Arthit Chairoungdua. Proteomics profiling of cholangiocarcinoma exosomes: A potential role of oncogenic protein transferring in cancer progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(9): 1989 doi: 10.1016/j.bbadis.2015.06.024
|
| 8 |
Eko Suyanto, Jaggaiah N. Gorantla, Maniganda Santi, Fatchiyah Fatchiyah, Mariena Ketudat-Cairns, Chutima Talabnin, James R. Ketudat Cairns. Enzymatic synthesis of phenolic acid glucosyl esters to test activities on cholangiocarcinoma cells. Applied Microbiology and Biotechnology 2024; 108(1) doi: 10.1007/s00253-023-12895-5
|
| 9 |
Pattaya Seeree, Tavan Janvilisri, Thaned Kangsamaksin, Rutaiwan Tohtong, Supeecha Kumkate. Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10874
|
| 10 |
Kasima Wasuworawong, Sittiruk Roytrakul, Atchara Paemanee, Kattaleeya Jindapornprasert, Waraporn Komyod. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/629367
|
| 11 |
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
|
| 12 |
Wunchana Seubwai, Chaisiri Wongkham, Anucha Puapairoj, Narong Khuntikeo, Sopit Wongkham. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma. Cancer 2007; 109(12): 2497 doi: 10.1002/cncr.22716
|
| 13 |
Supannika Sorin, Sho Kubota, Sofiane Hamidi, Takako Yokomizo‐Nakano, Kulthida Vaeteewoottacharn, Sopit Wongkham, Sakda Waraasawapati, Chawalit Pairojkul, Jie Bai, Mariko Morii, Guojun Sheng, Kanlayanee Sawanyawisuth, Goro Sashida. HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2‐dependent manner. The FASEB Journal 2022; 36(7) doi: 10.1096/fj.202200386R
|
| 14 |
Chalinee Nuntagowat, Kawin Leelawat, Rutaiwan Tohtong. NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation. Clinical & Experimental Metastasis 2010; 27(5): 295 doi: 10.1007/s10585-010-9327-y
|
| 15 |
Siriwat Sukphokkit, Pichamon Kiatwuthinon, Supeecha Kumkate, Tavan Janvilisri. Distinct cholangiocarcinoma cell migration in 2D monolayer and 3D spheroid culture based on galectin-3 expression and localization. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.999158
|
| 16 |
Piyanard Boonnate, Kulthida Vaeteewoottacharn, Ryusho Kariya, Sawako Fujikawa, Thidarut Boonmars, Somchai Pinlaor, Chawalit Pairojkul, Seiji Okada. Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases. In Vitro Cellular & Developmental Biology - Animal 2021; 57(8): 825 doi: 10.1007/s11626-021-00608-z
|
| 17 |
Ponlapat Yonglitthipagon, Chawalit Pairojkul, Yaovalux Chamgramol, Jason Mulvenna, Banchob Sripa. Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker. International Journal for Parasitology 2010; 40(10): 1203 doi: 10.1016/j.ijpara.2010.05.002
|
| 18 |
Ponlapat Yonglitthipagon, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi, Jason Mulvenna, Alex Loukas, Banchob Sripa. RETRACTED: Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma. Clinical Biochemistry 2012; 45(10-11): 827 doi: 10.1016/j.clinbiochem.2012.04.004
|
| 19 |
David A. Mayer, Bernard Fried. Advances in Parasitology Volume 65. Advances in Parasitology 2007; 65: 239 doi: 10.1016/S0065-308X(07)65004-0
|
| 20 |
Tomomi Towata, Yuji Komizu, Ryusho Kariya, Shinya Suzu, Yoko Matsumoto, Naoya Kobayashi, Chaisiri Wongkham, Sopit Wongkham, Ryuichi Ueoka, Seiji Okada. Hybrid liposomes inhibit the growth of Cholangiocarcinoma by induction of cell cycle arrest in G1 phase. Bioorganic & Medicinal Chemistry Letters 2010; 20(12): 3680 doi: 10.1016/j.bmcl.2010.04.091
|
| 21 |
Mutita Junking, Janya Grainok, Chutamas Thepmalee, Sopit Wongkham, Pa-thai Yenchitsomanus. Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA. Tumor Biology 2017; 39(10): 101042831773336 doi: 10.1177/1010428317733367
|
| 22 |
Teerapich Kasemsuk, Natthiya Saehlim, Patcharee Arsakhant, Gunya Sittithumcharee, Seiji Okada, Rungnapha Saeeng. A novel synthetic acanthoic acid analogues and their cytotoxic activity in cholangiocarcinoma cells. Bioorganic & Medicinal Chemistry 2021; 29: 115886 doi: 10.1016/j.bmc.2020.115886
|
| 23 |
Suphanthip Phusrisom, Laddawan Senggunprai, Auemduan Prawan, Sarinya Kongpetch, Upa Kukongviriyapan, Supawan Thawornchinsombut, Sirithon Siriamornpun, Theeraphan Chumroenphat, Ronnachai Changsri, Veerapol Kukongviriyapan. Anti-tumor activity of rice bran hydrolysates on migration, invasion and angiogenesis. Asian Pacific Journal of Tropical Biomedicine 2021; 11(7): 317 doi: 10.4103/2221-1691.317243
|
| 24 |
Jutharat Kulsantiwong, Sattrachai Prasopdee, Jiraporn Ruangsittichai, Wipaporn Ruangjirachuporn, Thidarut Boonmars, Vithoon Viyanant, Paola Pierossi, Paul D. N. Hebert, Smarn Tesana, Donald James Colgan. DNA Barcode Identification of Freshwater Snails in the Family Bithyniidae from Thailand. PLoS ONE 2013; 8(11): e79144 doi: 10.1371/journal.pone.0079144
|
| 25 |
Florian Posch, Felix Prinz, Amar Balihodzic, Christian Mayr, Tobias Kiesslich, Christiane Klec, Katharina Jonas, Dominik A. Barth, Jakob M. Riedl, Armin Gerger, Martin Pichler. MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms. Cancers 2021; 13(16): 3996 doi: 10.3390/cancers13163996
|
| 26 |
Piya Prajumwongs, Orawan Waenphimai, Kulthida Vaeteewoottacharn, Sopit Wongkham, Kanlayanee Sawanyawisuth. Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells. PeerJ 2021; 9: e10637 doi: 10.7717/peerj.10637
|
| 27 |
Kankamol Kerdkumthong, Wannarat Chanket, Phanthipha Runsaeng, Sutthipong Nanarong, Kawinnath Songsurin, Phonprapavee Tantimetta, Chanan Angsuthanasombat, Aratee Aroonkesorn, Sumalee Obchoei. Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines. Probiotics and Antimicrobial Proteins 2024; 16(3): 713 doi: 10.1007/s12602-023-10096-0
|
| 28 |
Wongwarut Boonyanugomol, Chariya Chomvarin, Chariya Hahnvajanawong, Banchob Sripa, Maria Kaparakis-Liaskos, Richard L. Ferrero, Yoshio Yamaoka. Helicobacter pylori cag Pathogenicity Island (cagPAI) Involved in Bacterial Internalization and IL-8 Induced Responses via NOD1- and MyD88-Dependent Mechanisms in Human Biliary Epithelial Cells. PLoS ONE 2013; 8(10): e77358 doi: 10.1371/journal.pone.0077358
|
| 29 |
Piyasiri Chueakwon, Peeranat Jatooratthawichot, Krajang Talabnin, James R. Ketudat Cairns, Chutima Talabnin. Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. Life 2022; 12(3): 351 doi: 10.3390/life12030351
|
| 30 |
Sopit Wongkham, Mutita Junking, Chaisiri Wongkham, Banchob Sripa, Siri Chur‐in, Norie Araki. Suppression of galectin‐3 expression enhances apoptosis and chemosensitivity in liver fluke‐associated cholangiocarcinoma. Cancer Science 2009; 100(11): 2077 doi: 10.1111/j.1349-7006.2009.01304.x
|
| 31 |
Norma Pangestu, Piyasiri Chueakwon, Krajang Talabnin, Juthamas Khiaowichit, Chutima Talabnin. RNF43 overexpression attenuates the Wnt/β‑catenin signalling pathway to suppress tumour progression in cholangiocarcinoma. Oncology Letters 2021; 22(6) doi: 10.3892/ol.2021.13107
|
| 32 |
Somkid Janeklang, Archawin Nakaew, Kulthida Vaeteewoottacharn, Wunchana Seubwai, Patcharee Boonsiri, Gorkem Kismali, Apichart Suksamrarn, Seiji Okada, Sopit Wongkham. In vitro and In vivo Antitumor Activity of Tiliacorinine in Human Cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention 2014; 15(17): 7473 doi: 10.7314/APJCP.2014.15.17.7473
|
| 33 |
Kittiya Islam, Parichut Thummarati, Pakkanun Kaewkong, Banchob Sripa, Tuangporn Suthiphongchai. Role of laminin and cognate receptors in cholangiocarcinoma cell migration. Cell Adhesion & Migration 2021; 15(1): 152 doi: 10.1080/19336918.2021.1924422
|
| 34 |
Supak Yothaisong, Nisana Namwat, Puangrat Yongvanit, Narong Khuntikeo, Anucha Puapairoj, Promsuk Jutabha, Naohiko Anzai, Wichittra Tassaneeyakul, Panot Tangsucharit, Watcharin Loilome. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. Parasitology International 2017; 66(4): 471 doi: 10.1016/j.parint.2015.11.011
|
| 35 |
Siriporn Proungvitaya, Wachiraya Klinthong, Tanakorn Proungvitaya, Temduang Limpaiboon, Patcharee Jearanaikoon, Sittiruk Roytrakul, Chaisiri Wongkham, Anongporn Nimboriboonporn, Sopit Wongkham. High expression of CCDC25 in cholangiocarcinoma tissue samples. Oncology Letters 2017; 14(2): 2566 doi: 10.3892/ol.2017.6446
|
| 36 |
Paksiree Saranaruk, Sakda Waraasawapati, Yaovalux Chamgramol, Kanlayanee Sawanyawisuth, Natnicha Paungpan, Narumon Somphud, Chaisiri Wongkham, Seiji Okada, Sopit Wongkham, Kulthida Vaeteewoottacharn. Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients. PeerJ 2023; 11: e14883 doi: 10.7717/peerj.14883
|
| 37 |
Nattakarn Nooron, Koji Ohba, Kazuhisa Takeda, Shigeki Shibahara, Anchalee Chiabchalard. Dysregulated Expression of MITF in Subsets of Hepatocellular Carcinoma and Cholangiocarcinoma. The Tohoku Journal of Experimental Medicine 2017; 242(4): 291 doi: 10.1620/tjem.242.291
|
| 38 |
Tueanjai Khunluck, Veerapol Kukongviriyapan, Laddawan Senggunprai, Wutthipong Duangarsong, Auemduan Prawan. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells. Integrative Cancer Therapies 2019; 18 doi: 10.1177/1534735418820444
|
| 39 |
Arunta Samankul, Gulsiri Senawong, Suppawit Utaiwat, Jeerati Prompipak, Khanutsanan Woranam, Chanokbhorn Phaosiri, Banchob Sripa, Thanaset Senawong. Tiliacora triandra Leaf Powder Ethanolic Extract in Combination with Cisplatin or Gemcitabine Synergistically Inhibits the Growth of Cholangiocarcinoma Cells In Vitro and in Nude Mouse Xenograft Models. Medicina 2023; 59(7): 1269 doi: 10.3390/medicina59071269
|
| 40 |
Tanachapa Jantalika, Sirikul Manochantr, Pakpoom Kheolamai, Duangrat Tantikanlayaporn, Weerachai Saijuntha, Somchai Pinlaor, Arthit Chairoungdua, Luminita Paraoan, Chairat Tantrawatpan. Human chorion-derived mesenchymal stem cells suppress JAK2/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-15298-0
|
| 41 |
Phorutai Pearngam, Supeecha Kumkate, Seiji Okada, Tavan Janvilisri. Andrographolide Inhibits Cholangiocarcinoma Cell Migration by Down-Regulation of Claudin-1 via the p-38 Signaling Pathway. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00827
|
| 42 |
Chutima Talabnin, Krajang Talabnin, Sopit Wongkham. Enhancement of piperlongumine chemosensitivity by silencing heme oxygenase‑1 expression in cholangiocarcinoma cell lines. Oncology Letters 2020; 20(3): 2483 doi: 10.3892/ol.2020.11784
|
| 43 |
Jeerati Prompipak, Thanaset Senawong, Banchob Sripa, Albert J. Ketterman, Suppawit Utaiwat, Khanutsanan Woranam, Jarckrit Jeeunngoi, Gulsiri Senawong. Anticancer effects of the combined Thai noni juice ethanolic extracts and 5-fluorouracil against cholangiocarcinoma cells in vitro and in vivo. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94049-z
|
| 44 |
Duangduen Krailas, Thanaporn Wongpim, Jirayus Komsuwan, Nuanpan Veeravechsukij, Chanyanuch Janmanee, Piyawan Thongchot, Wivitchuta Dechruksa, Saranphat Suwanrat, Kampanat Tharapoom, Matthias Glaubrecht. Prevalence and distribution of trematodes hosted by Bithynia siamensis in Southern Thailand. Parasitology Research 2024; 123(10) doi: 10.1007/s00436-024-08345-4
|
| 45 |
Chutipa Chiawpanit, Suthida Panwong, Nunghathai Sawasdee, Pa-thai Yenchitsomanus, Aussara Panya. Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells. Biology 2022; 11(8): 1098 doi: 10.3390/biology11081098
|
| 46 |
Wunchana Seubwai, Chaisiri Wongkham, Anucha Puapairoj, Narong Khuntikeo, Ake Pugkhem, Chariya Hahnvajanawong, Jariya Chaiyagool, Kazuo Umezawa, Seiji Okada, Sopit Wongkham, Makoto Makishima. Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy. PLoS ONE 2014; 9(8): e106056 doi: 10.1371/journal.pone.0106056
|
| 47 |
Wunchana Seubwai, Kulthida Vaeteewoottacharn, Ratthaphol Kraiklang, Kazuo Umezawa, Seiji Okada, Sopit Wongkham. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016; 23(1): 21 doi: 10.3727/096504015X14424348426071
|
| 48 |
Chariya Hahnvajanawong, Supaluk Ketnimit, Kovit Pattanapanyasat, Natthinee Anantachoke, Banchob Sripa, Khosit Pinmai, Wunchana Seubwai, Vichai Reutrakul. Involvement of p53 and Nuclear Factor-kappaB Signaling Pathway for the Induction of G1-Phase Cell Cycle Arrest of Cholangiocarcinoma Cell Lines by Isomorellin. Biological and Pharmaceutical Bulletin 2012; 35(11): 1914 doi: 10.1248/bpb.b12-00118
|
| 49 |
Handy Riantana, Orawan Waenphimai, Panupong Mahalapbutr, Kun Karnchanapandh, Kulthida Vaeteewoottacharn, Sopit Wongkham, Kanlayanee Sawanyawisuth. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines. Pathology - Research and Practice 2023; 248: 154678 doi: 10.1016/j.prp.2023.154678
|
| 50 |
Jomnarong Lertsuwan, Kornkamon Lertsuwan, Anyaporn Sawasdichai, Nathapol Tasnawijitwong, Ka Lee, Philip Kitchen, Simon Afford, Kevin Gaston, Padma-Sheela Jayaraman, Jutamaad Satayavivad. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers 2018; 10(9): 283 doi: 10.3390/cancers10090283
|
| 51 |
Prin Sungwan, Worachart Lert-itthiporn, Atit Silsirivanit, Nathakan Klinhom-on, Seiji Okada, Sopit Wongkham, Wunchana Seubwai. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. PeerJ 2021; 9: e11067 doi: 10.7717/peerj.11067
|
| 52 |
Giovanni Brandi, Simona Tavolari. Diagnosis and Management of Cholangiocarcinoma. 2021; : 471 doi: 10.1007/978-3-030-70936-5_22
|
| 53 |
Sirintip Boonjaraspinyo, Thidarut Boonmars, Zhiliang Wu, Watcharin Loilome, Paiboon Sithithaworn, Isao Nagano, Somchai Pinlaor, Puangrat Yongvanit, Phuangphaka Sadee Nielsen, Chawalit Pairojkul, Narong Khuntikeo. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma. Tumor Biology 2012; 33(5): 1785 doi: 10.1007/s13277-012-0438-8
|
| 54 |
Benchamart Moolmuang, Jittiporn Chaisaingmongkol, Pattama Singhirunnusorn, Mathuros Ruchirawat. PLK1 inhibition leads to mitotic arrest and triggers apoptosis in cholangiocarcinoma cells. Oncology Letters 2024; 28(1) doi: 10.3892/ol.2024.14449
|
| 55 |
Ubonrat Thamrongwaranggoon, Wunchana Seubwai, Chatchai Phoomak, Sakkarn Sangkhamanon, Ubon Cha'on, Thidarat Boonmars, Sopit Wongkham. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Biochemical and Biophysical Research Communications 2017; 484(2): 409 doi: 10.1016/j.bbrc.2017.01.139
|
| 56 |
Silvestre Vicent, Ruby Lieshout, Anna Saborowski, Monique M. A. Verstegen, Chiara Raggi, Stefania Recalcati, Pietro Invernizzi, Luc J. W. van der Laan, Domenico Alvaro, Diego F. Calvisi, Vincenzo Cardinale. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma. Liver International 2019; 39(S1): 79 doi: 10.1111/liv.14094
|
| 57 |
Nantana Suwandittakul, Onrapak Reamtong, Pattamaporn Molee, Santi Maneewatchararangsri, Maleerat Sutherat, Urai Chaisri, Sopit Wongkham, Poom Adisakwattana. Disruption of endocytic trafficking protein Rab7 impairs invasiveness of cholangiocarcinoma cells. Cancer Biomarkers 2017; 20(3): 255 doi: 10.3233/CBM-170030
|
| 58 |
Annamaria Massa, Chiara Varamo, Francesca Vita, Simona Tavolari, Caterina Peraldo-Neia, Giovanni Brandi, Alessandro Rizzo, Giuliana Cavalloni, Massimo Aglietta. Evolution of the Experimental Models of Cholangiocarcinoma. Cancers 2020; 12(8): 2308 doi: 10.3390/cancers12082308
|
| 59 |
Xiwei Ding, Kais Zakharia, Catherine D. Moser, Nellie A. Campbell, Chunling Hu, Nataliya Razumilava, Roongruedee Chaiteerakij, Hassan M. Shaleh, Patricia T. Greipp, Rondell P. Graham, Xiaoping Zou, Vishal S. Chandan, Lewis R. Roberts. Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27. Cancers 2022; 14(20): 5080 doi: 10.3390/cancers14205080
|
| 60 |
Phonpilas Thongpon, Kitti Intuyod, Sasitorn Chomwong, Thatsanapong Pongking, Sirinapha Klungsaeng, Kanha Muisuk, Naruechar Charoenram, Chutima Sitthirach, Raynoo Thanan, Porntip Pinlaor, Somchai Pinlaor. Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66945-7
|
| 61 |
Jutharat Kulsantiwong, Sattrachai Prasopdee, Supawadee Piratae, Panita Khampoosa, Apiporn Suwannatrai, Wipada Duangprompo, Thidarut Boonmars, Wipaporn Ruangjirachuporn, Jiraporn Ruangsittichai, Vithoon Viyanant, Paul D. N Hebert, Smarn Tesana. Species-Specific Primers Designed from RAPD Products forBithynia funiculata,the First Intermediate Host of Liver Fluke,Opisthorchis viverrini, in North Thailand. Journal of Parasitology 2013; 99(3): 433 doi: 10.1645/GE-3138.1
|
| 62 |
Marutpong Detarya, Kanlayanee Sawanyawisuth, Chaiwat Aphivatanasiri, Sriwipa Chuangchaiya, Paksiree Saranaruk, Lukkana Sukprasert, Atit Silsirivanit, Norie Araki, Sopit Wongkham, Chaisiri Wongkham. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. Glycobiology 2020; 30(5): 312 doi: 10.1093/glycob/cwz098
|
| 63 |
Kwuntida Uthaisar, Kulthida Vaeteewoottacharn, Wunchana Seubwai, Chutima Talabnin, Kanlayanee Sawanyawisuth, Sumalee Obchoei, Ratthaphol Kraiklang, Seiji Okada, Sopit Wongkham. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity. Oncology Reports 2016; 36(3): 1435 doi: 10.3892/or.2016.4974
|
| 64 |
Chatchai Phoomak, Kulthida Vaeteewoottacharn, Atit Silsirivanit, Charupong Saengboonmee, Wunchana Seubwai, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Sopit Wongkham. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation. Scientific Reports 2017; 7(1) doi: 10.1038/srep43842
|
| 65 |
Weijia Han, Qiao Wu, Xiaohui Zhang, Zhongping Duan. Innovation for hepatotoxicity in vitro research models: A review. Journal of Applied Toxicology 2019; 39(1): 146 doi: 10.1002/jat.3711
|
| 66 |
Suyanee Thongchot, Chiara Vidoni, Alessandra Ferraresi, Watcharin Loilome, Puangrat Yongvanit, Nisana Namwat, Ciro Isidoro. Dihydroartemisinin induces apoptosis and autophagy‐dependent cell death in cholangiocarcinoma through a DAPK1‐BECLIN1 pathway. Molecular Carcinogenesis 2018; 57(12): 1735 doi: 10.1002/mc.22893
|
| 67 |
Rucksak Rucksaken, Chawalit Pairojkul, Porntip Pinlaor, Narong Khuntikeo, Sittiruk Roytrakul, Carlo Selmi, Somchai Pinlaor, Gabriele Multhoff. Plasma Autoantibodies against Heat Shock Protein 70, Enolase 1 and Ribonuclease/Angiogenin Inhibitor 1 as Potential Biomarkers for Cholangiocarcinoma. PLoS ONE 2014; 9(7): e103259 doi: 10.1371/journal.pone.0103259
|
| 68 |
Waleeporn Kaewlert, Chadamas Sakonsinsiri, Worachart Lert-itthiporn, Panupong Mahalapbutr, Saba Ali, Thanyada Rungrotmongkol, Apinya Jusakul, Napat Armartmuntree, Chawalit Pairojkul, Guofei Feng, Ning Ma, Somchai Pinlaor, Mariko Murata, Raynoo Thanan. Buparlisib and ponatinib inhibit aggressiveness of cholangiocarcinoma cells via suppression of IRS1-related pathway by targeting oxidative stress resistance. Biomedicine & Pharmacotherapy 2024; 180: 117569 doi: 10.1016/j.biopha.2024.117569
|
| 69 |
Marutpong Detarya, Salak Thaenkaew, Wunchana Seubwai, Somsiri Indramanee, Chatchai Phoomak, Charupong Saengboonmee, Sopit Wongkham, Chaisiri Wongkham. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma. Life Sciences 2021; 271: 119114 doi: 10.1016/j.lfs.2021.119114
|
| 70 |
Thanich Sangsuwannukul, Kamonlapat Supimon, Thaweesak Chieochansin, Kornkan Choomee, Jatuporn Sujjitjoon, Mutita Junking, Pa-thai Yenchitsomanus, Yoshihiko Hirohashi. Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma. PLOS ONE 2022; 17(3): e0265773 doi: 10.1371/journal.pone.0265773
|
| 71 |
Nattapong Puthdee, Wunchana Seubwai, Kulthida Vaeteewoottacharn, Thidarut Boonmars, Ubon Cha’on, Chatchai Phoomak, Sopit Wongkham. Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines <i>via</i> Inhibition of NF-κB and STAT3 Pathways. Biological & Pharmaceutical Bulletin 2017; 40(6): 751 doi: 10.1248/bpb.b16-00428
|
| 72 |
Kulthida Vaeteewoottacharn, Ryusho Kariya, Kouki Matsuda, Manabu Taura, Chaisiri Wongkham, Sopit Wongkham, Seiji Okada. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology 2013; 139(9): 1551 doi: 10.1007/s00432-013-1473-6
|
| 73 |
Ornanong Tusskorn, Tueanjai Khunluck, Auemduan Prawan, Laddawan Senggunprai, Upa Kukongviriyapan, Veerapol Kukongviriyapan. Suppression of glutathione S-transferases potentiates the cytotoxic effect of phenethyl isothiocyanate in cholangiocarcinoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2018; 391(6): 657 doi: 10.1007/s00210-018-1492-6
|
| 74 |
Atit Silsirivanit, Norie Araki, Chaisiri Wongkham, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Kazuhiko Kuwahara, Yoshiki Narimatsu, Hiromichi Sawaki, Hisashi Narimatsu, Seiji Okada, Nobuo Sakaguchi, Sopit Wongkham. CA‐S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Cancer Science 2013; 104(10): 1278 doi: 10.1111/cas.12222
|
| 75 |
Giuliana Cavalloni, Caterina Peraldo-Neia, Chiara Varamo, Laura Casorzo, Carmine Dell’Aglio, Paola Bernabei, Giovanna Chiorino, Massimo Aglietta, Francesco Leone. Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient. Tumor Biology 2016; 37(3): 4041 doi: 10.1007/s13277-015-4215-3
|
| 76 |
Paiboon Sithithaworn, Banchob Sripa, Sasithorn Kaewkes, Jong Yil Chai, Yukifumi Nawa, Melissa R. Haswell. Manson's Tropical Diseases. 2024; : 734 doi: 10.1016/B978-0-7020-7959-7.00058-0
|
| 77 |
Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Ryusho Kariya, Kanha Muisuk, Kanokwan Imtawil, Yaovalux Chamgramol, Vajarabhongsa Bhudhisawasdi, Narong Khuntikeo, Ake Pugkhem, O-Tur Saeseow, Atit Silsirivanit, Chaisiri Wongkham, Sopit Wongkham, Seiji Okada. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model. Cells 2019; 8(5): 496 doi: 10.3390/cells8050496
|
| 78 |
Peti Thuwajit, Watinee Chawengrattanachot, Chanitra Thuwajit, Banchob Sripa, Felicity E. B. May, Bruce R. Westley, Nisana N. Tepsiri, Anucha Paupairoj, Siri Chau‐in. Increased TFF1 trefoil protein expression in Opisthorchis viverrini‐associated cholangiocarcinoma is important for invasive promotion. Hepatology Research 2007; 37(4): 295 doi: 10.1111/j.1872-034X.2007.00045.x
|
| 79 |
Thanich Sangsuwannukul, Kamonlapat Supimon, Jatuporn Sujjitjoon, Nattaporn Phanthaphol, Thaweesak Chieochansin, Naravat Poungvarin, Sopit Wongkham, Mutita Junking, Pa-thai Yenchitsomanus. Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells. International Immunopharmacology 2020; 89: 107069 doi: 10.1016/j.intimp.2020.107069
|
| 80 |
Doungdean Tummanatsakun, Tanakorn Proungvitaya, Sittiruk Roytrakul, Siriporn Proungvitaya. Bioinformatic Prediction of Signaling Pathways for Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) and Its Role in Cholangiocarcinoma Cells. Molecules 2021; 26(9): 2587 doi: 10.3390/molecules26092587
|
| 81 |
Panthip Rattanasinganchan, Kawin Leelawat, Sa-ard Treepongkaruna, Chintana Tocharoentanaphol, Somboon Subwongcharoen, Tuangporn Suthiphongchai, Rutaiwan Tohtong. Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. World Journal of Gastroenterology 2006; 12(40): 6500-6506 doi: 10.3748/wjg.v12.i40.6500
|
| 82 |
Boonyakorn Boonsri, Kiattawee Choowongkomon, Buabarn Kuaprasert, Thanvarin Thitiphatphuvanon, Kittiya Supradit, Apinya Sayinta, Jinchutha Duangdara, Tawut Rudtanatip, Kanokpan Wongprasert. Probing the Anti-Cancer Potency of Sulfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking, and In Vitro Studies. Marine Drugs 2021; 19(5): 258 doi: 10.3390/md19050258
|
| 83 |
Benchamart Moolmuang, Mathuros Ruchirawat. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. Journal of Pharmacy and Pharmacology 2021; 73(1): 40 doi: 10.1093/jpp/rgaa050
|
| 84 |
Kankamol Kerdkumthong, Sittiruk Roytrakul, Kawinnath Songsurin, Kandawasri Pratummanee, Phanthipha Runsaeng, Sumalee Obchoei. Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. Biomolecules 2024; 14(8): 969 doi: 10.3390/biom14080969
|
| 85 |
Michael J. Smout, Thewarach Laha, Jason Mulvenna, Banchob Sripa, Sutas Suttiprapa, Alun Jones, Paul J. Brindley, Alex Loukas, Edward J. Pearce. A Granulin-Like Growth Factor Secreted by the Carcinogenic Liver Fluke, Opisthorchis viverrini, Promotes Proliferation of Host Cells. PLoS Pathogens 2009; 5(10): e1000611 doi: 10.1371/journal.ppat.1000611
|
| 86 |
Paweena Dana, Saowaluk Saisomboon, Ryusho Kariya, Seiji Okada, Sumalee Obchoei, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Chawalit Pairojkul, Sopit Wongkham, Kulthida Vaeteewoottacharn. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion. Cellular Oncology 2020; 43(2): 211 doi: 10.1007/s13402-019-00479-3
|
| 87 |
Bernard Fried, Aditya Reddy, David Mayer. Helminths in human carcinogenesis. Cancer Letters 2011; 305(2): 239 doi: 10.1016/j.canlet.2010.07.008
|
| 88 |
Wunchana Seubwai, Chaisiri Wongkham, Anucha Puapairoj, Seiji Okada, Sopit Wongkham. 22‐Oxa‐1,25‐dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculutre of cholangiocarcinoma. Cancer 2010; 116(23): 5535 doi: 10.1002/cncr.25478
|
| 89 |
Michael J. Smout, Jason P. Mulvenna, Malcolm K. Jones, Alex Loukas. Expression, refolding and purification of Ov-GRN-1, a granulin-like growth factor from the carcinogenic liver fluke, that causes proliferation of mammalian host cells. Protein Expression and Purification 2011; 79(2): 263 doi: 10.1016/j.pep.2011.06.018
|
| 90 |
Paiboon Sithithaworn, Banchob Sripa, Sasithorn Kaewkes, Yukifumi Nawa, Melissa R. Haswell. Manson's Tropical Infectious Diseases. 2014; : 726 doi: 10.1016/B978-0-7020-5101-2.00054-6
|
| 91 |
Potjamas Pansri, Nanthnit Jaruseranee, Kuntalee Rangnoi, Peter Kristensen, Montarop Yamabhai. A compact phage display human scFv library for selection of antibodies to a wide variety of antigens. BMC Biotechnology 2009; 9(1) doi: 10.1186/1472-6750-9-6
|
| 92 |
Christian Mayr, Tobias Kiesslich, Dino Bekric, Marlena Beyreis, Michael Kittl, Celina Ablinger, Elen Neureiter, Martin Pichler, Felix Prinz, Markus Ritter, Daniel Neureiter, Martin Jakab, Heidemarie Dobias, Luis Eduardo M. Quintas. Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells. PLOS ONE 2023; 18(6): e0287769 doi: 10.1371/journal.pone.0287769
|
| 93 |
KUSUMAWADEE UTISPAN, JUMAPORN SONONGBUA, PETI THUWAJIT, SIRI CHAU-IN, CHAWALIT PAIROJKUL, SOPIT WONGKHAM, CHANITRA THUWAJIT. Periostin activates integrin α5β1 through a PI3K/AKT-dependent pathway in invasion of cholangiocarcinoma. International Journal of Oncology 2012; 41(3): 1110 doi: 10.3892/ijo.2012.1530
|
| 94 |
Waraporn Saentaweesuk, Norie Araki, Kulthida Vaeteewoottacharn, Atit Silsirivanit, Wunchana Seubwai, Chutima Talabnin, Kanha Muisuk, Banchob Sripa, Sopit Wongkham, Seiji Okada, Chaisiri Wongkham. Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(4): 605 doi: 10.3727/096504017X15009778205068
|
| 95 |
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48798-8
|
| 96 |
Taweewun Hunsawong, Ekapot Singsuksawat, Nuannapa In-chon, Watinee Chawengrattanachot, Chanitra Thuwajit, Banchob Sripa, Anucha Paupairoj, Siri Chau-in, Peti Thuwajit. Estrogen is increased in male cholangiocarcinoma patients’ serum and stimulates invasion in cholangiocarcinoma cell lines in vitro. Journal of Cancer Research and Clinical Oncology 2012; 138(8): 1311 doi: 10.1007/s00432-012-1207-1
|
| 97 |
Ming‐Hung Hu, Tzu‐Ting Huang, Tzu‐I Chao, Li‐Ju Chen, Yen‐Lin Chen, Ming‐Hsien Tsai, Chun‐Yu Liu, Jia‐Horng Kao, Kuen‐Feng Chen. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma. Liver International 2018; 38(12): 2248 doi: 10.1111/liv.13887
|
| 98 |
Son Dinh An Truong, Molin Wongwattanakul, Tanakorn Proungvitaya, Temduang Limpaiboon, Sittiruk Roytrakul, Daraporn Chua-on, Doungdean Tummanatsakun, Siriporn Proungvitaya. Prediction of CIAPIN1 (Cytokine-Induced Apoptosis Inhibitor 1) Signaling Pathway and Its Role in Cholangiocarcinoma Metastasis. Journal of Clinical Medicine 2022; 11(13): 3826 doi: 10.3390/jcm11133826
|
| 99 |
Philip Kitchen, Ka Ying Lee, Danielle Clark, Nikki Lau, Jomnarong Lertsuwan, Anyaporn Sawasdichai, Jutamaad Satayavivad, Sebastian Oltean, Simon Afford, Kevin Gaston, Padma-Sheela Jayaraman. A Runaway PRH/HHEX-Notch3–Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Research 2020; 80(4): 757 doi: 10.1158/0008-5472.CAN-19-0942
|
| 100 |
Papavee Samatiwat, Auemduan Prawan, Laddawan Senggunprai, Upa Kukongviriyapan, Veerapol Kukongviriyapan. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents. Tumor Biology 2016; 37(8): 11495 doi: 10.1007/s13277-016-5015-0
|
| 101 |
Sirinapa Sribenja, Kanlayanee Sawanyawisuth, Ratthaphol Kraiklang, Chaisiri Wongkham, Kulthida Vaeteewoottacharn, Sumalee Obchoei, Qizhi Yao, Sopit Wongkham, Changyi Chen. Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-430
|
| 102 |
Tanachapa Jantalika, Sirikul Manochantr, Pakpoom Kheolamai, Duangrat Tantikanlayaporn, Nattaya Thongsepee, Naree Warnnissorn, Weerachai Saijuntha, Somchai Pinlaor, Chairat Tantrawatpan. The Human Placental Amniotic Membrane Mesenchymal-Stromal-Cell-Derived Conditioned Medium Inhibits Growth and Promotes Apoptosis of Human Cholangiocarcinoma Cells In Vitro and In Vivo by Suppressing IL-6/JAK2/STAT3 Signaling. Cells 2023; 12(24): 2788 doi: 10.3390/cells12242788
|
| 103 |
Paksiree Saranaruk, Ryusho Kariya, Gunya Sittithumcharee, Parichart Boueroy, Thidarut Boonmars, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Sopit Wongkham, Seiji Okada, Kulthida Vaeteewoottacharn. Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1‑related anti‑apoptotic proteins. International Journal of Molecular Medicine 2020; doi: 10.3892/ijmm.2020.4482
|
| 104 |
Siriwoot Butsri, Veerapol Kukongviriyapan, Laddawan Senggunprai, Sarinya Kongpetch, Auemduan Prawan. All‑trans‑retinoic acid induces RARB‑dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. Oncology Letters 2022; 23(6) doi: 10.3892/ol.2022.13299
|
| 105 |
Wongwarut Boonyanugomol, Chariya Chomvarin, Seung-Chul Baik, Jea-Young Song, Chariya Hahnvajanawong, Kyung-Mi Kim, Myung-Je Cho, Woo-Kon Lee, Hyung-Lyun Kang, Kwang-Ho Rhee, Banchob Sripa. Role of cagA-Positive Helicobacter pylori on Cell Proliferation, Apoptosis, and Inflammation in Biliary Cells. Digestive Diseases and Sciences 2011; 56(6): 1682 doi: 10.1007/s10620-010-1512-y
|
| 106 |
Paweena Dana, Ryusho Kariya, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Wunchana Seubwai, Kouki Matsuda, Seiji Okada, Sopit Wongkham. Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(7): 1047 doi: 10.3727/096504016X14813899000565
|
| 107 |
Nathakan Klinhom-on, Wunchana Seubwai, Kanlayanee Sawanyawisuth, Sumalee Obchoei, Panupong Mahalapbutr, Sopit Wongkham. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. Life Sciences 2021; 286: 120072 doi: 10.1016/j.lfs.2021.120072
|
| 108 |
Raynoo Thanan, Waleeporn Kaewlert, Chadamas Sakonsinsiri, Timpika Chaiprasert, Napat Armartmuntree, Duangkamon Muengsaen, Anchalee Techasen, Poramate Klanrit, Worachart Lert-itthiporn, Somchai Pinlaor, Chawalit Pairojkul. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression. International Journal of Molecular Sciences 2020; 21(5): 1796 doi: 10.3390/ijms21051796
|
| 109 |
Abdulkadir Isidan, Ali Yenigun, Daiki Soma, Eric Aksu, Kevin Lopez, Yujin Park, Arthur Cross-Najafi, Ping Li, Debjyoti Kundu, Michael G. House, Sanjukta Chakraborty, Shannon Glaser, Lindsey Kennedy, Heather Francis, Wenjun Zhang, Gianfranco Alpini, Burcin Ekser. Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines. The American Journal of Pathology 2022; 192(9): 1200 doi: 10.1016/j.ajpath.2022.05.007
|
| 110 |
Mutita Junking, Chaisiri Wongkham, Banchob Sripa, Kanlayanee Sawanyawisuth, Norie Araki, Sopit Wongkham. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. European Journal of Cancer 2008; 44(4): 619 doi: 10.1016/j.ejca.2008.01.014
|
| 111 |
Tawit Suriyo, Mayuree Fuangthong, Charlermchai Artpradit, Teerapat Ungtrakul, Thaniya Sricharunrat, Fatma Taha, Jutamaad Satayavivad. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells. European Journal of Pharmacology 2021; 897: 173960 doi: 10.1016/j.ejphar.2021.173960
|
| 112 |
Supawan Jamnongsong, Patipark Kueanjinda, Pongsakorn Buraphat, Phuwanat Sakornsakolpat, Kulthida Vaeteewoottacharn, Seiji Okada, Siwanon Jirawatnotai, Somponnat Sampattavanich. Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma. iScience 2022; 25(10): 105182 doi: 10.1016/j.isci.2022.105182
|
| 113 |
Suthida Panwong, Methi Wathikthinnakon, Thida Kaewkod, Nunghathai Sawasdee, Yingmanee Tragoolpua, Pa-thai Yenchitsomanus, Aussara Panya. Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells. Molecules 2021; 26(19): 5973 doi: 10.3390/molecules26195973
|
| 114 |
Papavee Samatiwat, Auemduan Prawan, Laddawan Senggunprai, Veerapol Kukongviriyapan. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2015; 388(6): 601 doi: 10.1007/s00210-015-1101-x
|
| 115 |
Hiroaki Sugiyama, Kenichiro Onuki, Kazunori Ishige, Nobue Baba, Tetsuya Ueda, Sachiko Matsuda, Kaoru Takeuchi, Masafumi Onodera, Yasuni Nakanuma, Masayuki Yamato, Masakazu Yamamoto, Ichinosuke Hyodo, Junichi Shoda. Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells. Journal of Gastroenterology 2011; 46(6): 779 doi: 10.1007/s00535-011-0380-3
|
| 116 |
Orawan Waenphimai, Panupong Mahalapbutr, Kulthida Vaeteewoottacharn, Sopit Wongkham, Kanlayanee Sawanyawisuth. Multiple actions of NMS-P715, the monopolar spindle 1 (MPS1) mitotic checkpoint inhibitor in liver fluke-associated cholangiocarcinoma cells. European Journal of Pharmacology 2022; 922: 174899 doi: 10.1016/j.ejphar.2022.174899
|
| 117 |
Sureerat Padthaisong, Hasaya Dokduang, Supak Yothaisong, Anchalee Techasen, Nisana Namwat, Puangrat Yongvanit, Narong Khuntikeo, Attapol Titapun, Sakkarn Sangkhamanon, Watcharin Loilome. Inhibitory effect of NVP‑BKM120 on cholangiocarcinoma cell growth. Oncology Letters 2018; doi: 10.3892/ol.2018.8848
|
| 118 |
Worawat Songjang, Arunya Jiraviriyakul. Honokiol and Magnolol Inhibit Growth, Metastasis and Induce Apoptosis in Human Cholangiocarcinoma. Biomedical and Pharmacology Journal 2019; 12(2): 759 doi: 10.13005/bpj/1698
|
| 119 |
Rattanaporn Jaidee, Veerapol Kukongviriyapan, Laddawan Senggunprai, Auemduan Prawan, Apinya Jusakul, Phatthamon Laphanuwat, Sarinya Kongpetch. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. Life Sciences 2022; 296: 120427 doi: 10.1016/j.lfs.2022.120427
|
| 120 |
Felix Prinz, Katharina Jonas, Amar Balihodzic, Christiane Klec, Andreas Reicher, Dominik Andreas Barth, Jakob Riedl, Armin Gerger, Tobias Kiesslich, Christian Mayr, Beate Rinner, Julia Kargl, Martin Pichler. MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response. RNA Biology 2022; 19(1): 1305 doi: 10.1080/15476286.2022.2152978
|
| 121 |
Sunitta Saensa-ard, Saman Leuangwattanawanit, Laddawan Senggunprai, Nisana Namwat, Sarinya Kongpetch, Yaovalux Chamgramol, Watcharin Loilome, Walaiporn Khansaard, Apinya Jusakul, Auemduan Prawan, Chawalit Pairojkul, Narong Khantikeo, Puangrat Yongvanit, Veerapol Kukongviriyapan. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand. Tumor Biology 2017; 39(11): 101042831772592 doi: 10.1177/1010428317725925
|
| 122 |
Sumalee Obchoei, Sarah M Weakley, Sopit Wongkham, Chaisiri Wongkham, Kanlayanee Sawanyawisuth, Qizhi Yao, Changyi Chen. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Molecular Cancer 2011; 10(1) doi: 10.1186/1476-4598-10-102
|
| 123 |
B. J. VENNERVALD, K. POLMAN. Helminths and malignancy. Parasite Immunology 2009; 31(11): 686 doi: 10.1111/j.1365-3024.2009.01163.x
|
| 124 |
Papavee Samatiwat, Kazuhisa Takeda, Soisungwan Satarug, Koji Ohba, Veerapol Kukongviriyapan, Shigeki Shibahara. Induction of MITF expression in human cholangiocarcinoma cells and hepatocellular carcinoma cells by cyclopamine, an inhibitor of the Hedgehog signaling. Biochemical and Biophysical Research Communications 2016; 470(1): 144 doi: 10.1016/j.bbrc.2016.01.010
|
| 125 |
Saowaluk Saisomboon, Ryusho Kariya, Piyanard Boonnate, Kanlayanee Sawanyawisuth, Ubon Cha'on, Vor Luvira, Yaovalux Chamgramol, Chawalit Pairojkul, Wunchana Seubwai, Atit Silsirivanit, Sopit Wongkham, Seiji Okada, Sarawut Jitrapakdee, Kulthida Vaeteewoottacharn. Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(5): 166694 doi: 10.1016/j.bbadis.2023.166694
|
| 126 |
Atiroch Papatpremsiri, Michael J. Smout, Alex Loukas, Paul J. Brindley, Banchob Sripa, Thewarach Laha. Suppression of Ov-grn-1 encoding granulin of Opisthorchis viverrini inhibits proliferation of biliary epithelial cells. Experimental Parasitology 2015; 148: 17 doi: 10.1016/j.exppara.2014.11.004
|
| 127 |
Nathakan Klinhom-on, Wunchana Seubwai, Kanlayanee Sawanyawisuth, Worachart Lert-itthiporn, Sakda Waraasawapati, Marutpong Detarya, Sopit Wongkham. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients. Heliyon 2021; 7(4): e06846 doi: 10.1016/j.heliyon.2021.e06846
|
| 128 |
Suchada Phimsen, Kazuhiko Kuwahara, Teruo Nakaya, Kazutaka Ohta, Taiji Suda, Andri Rezano, Masahiro Kitabatake, Kulthida Vaeteewoottacharn, Seiji Okada, Shigenobu Tone, Nobuo Sakaguchi. Selective cell death of p53-insufficient cancer cells is induced by knockdown of the mRNA export molecule GANP. Apoptosis 2012; 17(7): 679 doi: 10.1007/s10495-012-0711-8
|
| 129 |
Sarunya Kitdumrongthum, Chanatip Metheetrairut, Varodom Charoensawan, Puey Ounjai, Keatdamrong Janpipatkul, Wittaya Panvongsa, Jittima Weerachayaphorn, Pawinee Piyachaturawat, Arthit Chairoungdua. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes. Life Sciences 2018; 210: 65 doi: 10.1016/j.lfs.2018.08.058
|
| 130 |
Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert. Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells. Cancer Research and Treatment 2021; 53(2): 457 doi: 10.4143/crt.2020.585
|
| 131 |
Banchob Sripa, Wunchana Seubwai, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Atit Silsirivanit, Worasak Kaewkong, Kanha Muisuk, Paweena Dana, Chatchai Phoomak, Worachart Lert-itthiporn, Vor Luvira, Chawalit Pairojkul, Bin T. Teh, Sopit Wongkham, Seiji Okada, Yaovalux Chamgramol. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Human Cell 2020; 33(3): 695 doi: 10.1007/s13577-020-00334-w
|
| 132 |
Dino Bekric, Tobias Kiesslich, Matthias Ocker, Martina Winklmayr, Markus Ritter, Heidemarie Dobias, Marlena Beyreis, Daniel Neureiter, Christian Mayr, Hiroyasu Nakano. The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells. PLOS ONE 2024; 19(4): e0302050 doi: 10.1371/journal.pone.0302050
|
| 133 |
Kulthida Vaeteewoottacharn, Ryusho Kariya, Paweena Dana, Sawako Fujikawa, Kouki Matsuda, Koichi Ohkuma, Eriko Kudo, Ratthaphol Kraiklang, Chaisiri Wongkham, Sopit Wongkham, Seiji Okada. Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma. Tumor Biology 2016; 37(7): 9023 doi: 10.1007/s13277-016-4785-8
|
| 134 |
Yanhua Zhang, Jingfeng Luo, Xue Dong, Fang Yang, Miaofeng Zhang, Juanjuan Zhao, Qiangfeng Wang, Fei Zhou, Jihong Sun, Xiaoming Yang. Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines. Annals of Surgical Oncology 2019; 26(12): 4134 doi: 10.1245/s10434-019-07649-5
|
| 135 |
Siriwoot Butsri, Veerapol Kukongviriyapan, Laddawan Senggunprai, Sarinya Kongpetch, Ponsilp Zeekpudsa, Auemduan Prawan. Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells. Oncology Letters 2017; 13(6): 4540 doi: 10.3892/ol.2017.5951
|
| 136 |
S. Kongpetch, A. Puapairoj, C. K. Ong, L. Senggunprai, A. Prawan, U. Kukongviriyapan, W. Chan‐On, E. Y. Siew, N. Khuntikeo, B. T. Teh, V. Kukongviriyapan. Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice. Cell Proliferation 2016; 49(1): 90 doi: 10.1111/cpr.12228
|
| 137 |
Owen McGreevy, Mohammed Bosakhar, Timothy Gilbert, Marc Quinn, Stephen Fenwick, Hassan Malik, Christopher Goldring, Laura Randle. The importance of preclinical models in cholangiocarcinoma. European Journal of Surgical Oncology 2024; : 108304 doi: 10.1016/j.ejso.2024.108304
|
| 138 |
Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Chawalit Pairojkul, O-Tur Saeseow, Gregory J. Riggins, Norie Araki, Sopit Wongkham. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: Potential for drug target. Acta Oncologica 2007; 46(3): 378 doi: 10.1080/02841860600871061
|
| 139 |
Sutthiwan Janthamala, Apinya Jusakul, Sarinya Kongpetch, Phongsaran Kimawaha, Poramate Klanrit, Watcharin Loilome, Nisana Namwat, Anchalee Techasen. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(10): 2049 doi: 10.1007/s00210-021-02123-0
|
| 140 |
Sumalee Obchoei, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Watchara Kasinrerk, Qizhi Yao, Changyi Chen, Sopit Wongkham. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway. Tumor Biology 2015; 36(2): 849 doi: 10.1007/s13277-014-2691-5
|
| 141 |
Kahori Seto, Junichi Shoda, Tomohisa Horibe, Eiji Warabi, Masayuki Kohno, Toru Yanagawa, Hiroki Bukawa, Yasuni Nakanuma, Koji Kawakami. Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy. International Journal of Hepatology 2014; 2014: 1 doi: 10.1155/2014/584650
|
| 142 |
Toru Kawamoto, Kazunori Ishige, Melanie Thomas, Yoriko Yamashita-Kashima, Sei Shu, Nobuyuki Ishikura, Shunichi Ariizumi, Masakazu Yamamoto, Kunihiko Kurosaki, Junichi Shoda. Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab. Journal of Gastroenterology 2015; 50(4): 467 doi: 10.1007/s00535-014-0984-5
|
| 143 |
Paweena Dana, Ryusho Kariya, Worachart Lert-itthiporn, Wunchana Seubwai, Saowaluk Saisomboon, Chaisiri Wongkham, Seiji Okada, Sopit Wongkham, Kulthida Vaeteewoottacharn. Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway. International Journal of Molecular Sciences 2021; 22(24): 13496 doi: 10.3390/ijms222413496
|
| 144 |
Piya Prajumwongs, Ratthaphong Phumphu, Orawan Waenphimai, Worachart Lert-itthiporn, Kulthida Vaeteewoottacharn, Sopit Wongkham, Yaovalux Chamgramol, Chawalit Pairojkul, Kanlayanee Sawanyawisuth. High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways. Biomedicines 2021; 9(1): 68 doi: 10.3390/biomedicines9010068
|
| 145 |
Ornanong Tusskorn, Auemduan Prawan, Laddawan Senggunprai, Upa Kukongviriyapan, Veerapol Kukongviriyapan. Phenethyl isothiocyanate induces apoptosis of cholangiocarcinoma cells through interruption of glutathione and mitochondrial pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2013; 386(11): 1009 doi: 10.1007/s00210-013-0906-8
|